Cargando…

Differences in Atrial Remodeling in Hypertrophic Cardiomyopathy Compared to Hypertensive Heart Disease and Athletes’ Hearts

Background: Hypertrophic cardiomyopathy (HCM), hypertensive heart disease (HHD) and athletes’ heart share an increased prevalence of atrial fibrillation. Atrial cardiomyopathy in these patients may have different characteristics and help to distinguish these conditions. Methods: In this single-cente...

Descripción completa

Detalles Bibliográficos
Autores principales: Servatius, Helge, Raab, Simon, Asatryan, Babken, Haeberlin, Andreas, Branca, Mattia, de Marchi, Stefano, Brugger, Nicolas, Nozica, Nikolas, Goulouti, Eleni, Elchinova, Elena, Lam, Anna, Seiler, Jens, Noti, Fabian, Madaffari, Antonio, Tanner, Hildegard, Baldinger, Samuel H., Reichlin, Tobias, Wilhelm, Matthias, Roten, Laurent
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8910879/
https://www.ncbi.nlm.nih.gov/pubmed/35268407
http://dx.doi.org/10.3390/jcm11051316
_version_ 1784666605197721600
author Servatius, Helge
Raab, Simon
Asatryan, Babken
Haeberlin, Andreas
Branca, Mattia
de Marchi, Stefano
Brugger, Nicolas
Nozica, Nikolas
Goulouti, Eleni
Elchinova, Elena
Lam, Anna
Seiler, Jens
Noti, Fabian
Madaffari, Antonio
Tanner, Hildegard
Baldinger, Samuel H.
Reichlin, Tobias
Wilhelm, Matthias
Roten, Laurent
author_facet Servatius, Helge
Raab, Simon
Asatryan, Babken
Haeberlin, Andreas
Branca, Mattia
de Marchi, Stefano
Brugger, Nicolas
Nozica, Nikolas
Goulouti, Eleni
Elchinova, Elena
Lam, Anna
Seiler, Jens
Noti, Fabian
Madaffari, Antonio
Tanner, Hildegard
Baldinger, Samuel H.
Reichlin, Tobias
Wilhelm, Matthias
Roten, Laurent
author_sort Servatius, Helge
collection PubMed
description Background: Hypertrophic cardiomyopathy (HCM), hypertensive heart disease (HHD) and athletes’ heart share an increased prevalence of atrial fibrillation. Atrial cardiomyopathy in these patients may have different characteristics and help to distinguish these conditions. Methods: In this single-center study, we prospectively collected and analyzed electrocardiographic (12-lead ECG, signal-averaged ECG (SAECG), 24 h Holter ECG) and echocardiographic data in patients with HCM and HHD and in endurance athletes. Patients with atrial fibrillation were excluded. Results: We compared data of 27 patients with HCM (70% males, mean age 50 ± 14 years), 324 patients with HHD (52% males, mean age 75 ± 5.5 years), and 215 endurance athletes (72% males, mean age 42 ± 7.5 years). HCM patients had significantly longer filtered P-wave duration (153 ± 26 ms) and PR interval (191 ± 48 ms) compared to HHD patients (144 ± 16 ms, p = 0.012 and 178 ± 31, p = 0.034, respectively) and athletes (134 ± 14 ms, p = 0.001 and 165 ± 26 ms, both p < 0.001, respectively). HCM patients had a mean of 4.9 ± 16 premature atrial complexes per hour. Premature atrial complexes per hour were significantly more frequent in HHD patients (27 ± 86, p < 0.001), but not in athletes (2.7 ± 23, p = 0.639). Left atrial volume index (LAVI) was 43 ± 14 mL/m(2) in HCM patients and significantly larger than age- and sex-corrected LAVI in HHD patients 30 ± 10 mL/m(2); p < 0.001) and athletes (31 ± 9.5 mL/m(2); p < 0.001). A borderline interventricular septum thickness ≥13 mm and ≤15 mm was found in 114 (35%) HHD patients, 12 (6%) athletes and 3 (11%) HCM patients. Conclusions: Structural and electrical atrial remodeling is more advanced in HCM patients compared to HHD patients and athletes.
format Online
Article
Text
id pubmed-8910879
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-89108792022-03-11 Differences in Atrial Remodeling in Hypertrophic Cardiomyopathy Compared to Hypertensive Heart Disease and Athletes’ Hearts Servatius, Helge Raab, Simon Asatryan, Babken Haeberlin, Andreas Branca, Mattia de Marchi, Stefano Brugger, Nicolas Nozica, Nikolas Goulouti, Eleni Elchinova, Elena Lam, Anna Seiler, Jens Noti, Fabian Madaffari, Antonio Tanner, Hildegard Baldinger, Samuel H. Reichlin, Tobias Wilhelm, Matthias Roten, Laurent J Clin Med Article Background: Hypertrophic cardiomyopathy (HCM), hypertensive heart disease (HHD) and athletes’ heart share an increased prevalence of atrial fibrillation. Atrial cardiomyopathy in these patients may have different characteristics and help to distinguish these conditions. Methods: In this single-center study, we prospectively collected and analyzed electrocardiographic (12-lead ECG, signal-averaged ECG (SAECG), 24 h Holter ECG) and echocardiographic data in patients with HCM and HHD and in endurance athletes. Patients with atrial fibrillation were excluded. Results: We compared data of 27 patients with HCM (70% males, mean age 50 ± 14 years), 324 patients with HHD (52% males, mean age 75 ± 5.5 years), and 215 endurance athletes (72% males, mean age 42 ± 7.5 years). HCM patients had significantly longer filtered P-wave duration (153 ± 26 ms) and PR interval (191 ± 48 ms) compared to HHD patients (144 ± 16 ms, p = 0.012 and 178 ± 31, p = 0.034, respectively) and athletes (134 ± 14 ms, p = 0.001 and 165 ± 26 ms, both p < 0.001, respectively). HCM patients had a mean of 4.9 ± 16 premature atrial complexes per hour. Premature atrial complexes per hour were significantly more frequent in HHD patients (27 ± 86, p < 0.001), but not in athletes (2.7 ± 23, p = 0.639). Left atrial volume index (LAVI) was 43 ± 14 mL/m(2) in HCM patients and significantly larger than age- and sex-corrected LAVI in HHD patients 30 ± 10 mL/m(2); p < 0.001) and athletes (31 ± 9.5 mL/m(2); p < 0.001). A borderline interventricular septum thickness ≥13 mm and ≤15 mm was found in 114 (35%) HHD patients, 12 (6%) athletes and 3 (11%) HCM patients. Conclusions: Structural and electrical atrial remodeling is more advanced in HCM patients compared to HHD patients and athletes. MDPI 2022-02-27 /pmc/articles/PMC8910879/ /pubmed/35268407 http://dx.doi.org/10.3390/jcm11051316 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Servatius, Helge
Raab, Simon
Asatryan, Babken
Haeberlin, Andreas
Branca, Mattia
de Marchi, Stefano
Brugger, Nicolas
Nozica, Nikolas
Goulouti, Eleni
Elchinova, Elena
Lam, Anna
Seiler, Jens
Noti, Fabian
Madaffari, Antonio
Tanner, Hildegard
Baldinger, Samuel H.
Reichlin, Tobias
Wilhelm, Matthias
Roten, Laurent
Differences in Atrial Remodeling in Hypertrophic Cardiomyopathy Compared to Hypertensive Heart Disease and Athletes’ Hearts
title Differences in Atrial Remodeling in Hypertrophic Cardiomyopathy Compared to Hypertensive Heart Disease and Athletes’ Hearts
title_full Differences in Atrial Remodeling in Hypertrophic Cardiomyopathy Compared to Hypertensive Heart Disease and Athletes’ Hearts
title_fullStr Differences in Atrial Remodeling in Hypertrophic Cardiomyopathy Compared to Hypertensive Heart Disease and Athletes’ Hearts
title_full_unstemmed Differences in Atrial Remodeling in Hypertrophic Cardiomyopathy Compared to Hypertensive Heart Disease and Athletes’ Hearts
title_short Differences in Atrial Remodeling in Hypertrophic Cardiomyopathy Compared to Hypertensive Heart Disease and Athletes’ Hearts
title_sort differences in atrial remodeling in hypertrophic cardiomyopathy compared to hypertensive heart disease and athletes’ hearts
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8910879/
https://www.ncbi.nlm.nih.gov/pubmed/35268407
http://dx.doi.org/10.3390/jcm11051316
work_keys_str_mv AT servatiushelge differencesinatrialremodelinginhypertrophiccardiomyopathycomparedtohypertensiveheartdiseaseandathleteshearts
AT raabsimon differencesinatrialremodelinginhypertrophiccardiomyopathycomparedtohypertensiveheartdiseaseandathleteshearts
AT asatryanbabken differencesinatrialremodelinginhypertrophiccardiomyopathycomparedtohypertensiveheartdiseaseandathleteshearts
AT haeberlinandreas differencesinatrialremodelinginhypertrophiccardiomyopathycomparedtohypertensiveheartdiseaseandathleteshearts
AT brancamattia differencesinatrialremodelinginhypertrophiccardiomyopathycomparedtohypertensiveheartdiseaseandathleteshearts
AT demarchistefano differencesinatrialremodelinginhypertrophiccardiomyopathycomparedtohypertensiveheartdiseaseandathleteshearts
AT bruggernicolas differencesinatrialremodelinginhypertrophiccardiomyopathycomparedtohypertensiveheartdiseaseandathleteshearts
AT nozicanikolas differencesinatrialremodelinginhypertrophiccardiomyopathycomparedtohypertensiveheartdiseaseandathleteshearts
AT gouloutieleni differencesinatrialremodelinginhypertrophiccardiomyopathycomparedtohypertensiveheartdiseaseandathleteshearts
AT elchinovaelena differencesinatrialremodelinginhypertrophiccardiomyopathycomparedtohypertensiveheartdiseaseandathleteshearts
AT lamanna differencesinatrialremodelinginhypertrophiccardiomyopathycomparedtohypertensiveheartdiseaseandathleteshearts
AT seilerjens differencesinatrialremodelinginhypertrophiccardiomyopathycomparedtohypertensiveheartdiseaseandathleteshearts
AT notifabian differencesinatrialremodelinginhypertrophiccardiomyopathycomparedtohypertensiveheartdiseaseandathleteshearts
AT madaffariantonio differencesinatrialremodelinginhypertrophiccardiomyopathycomparedtohypertensiveheartdiseaseandathleteshearts
AT tannerhildegard differencesinatrialremodelinginhypertrophiccardiomyopathycomparedtohypertensiveheartdiseaseandathleteshearts
AT baldingersamuelh differencesinatrialremodelinginhypertrophiccardiomyopathycomparedtohypertensiveheartdiseaseandathleteshearts
AT reichlintobias differencesinatrialremodelinginhypertrophiccardiomyopathycomparedtohypertensiveheartdiseaseandathleteshearts
AT wilhelmmatthias differencesinatrialremodelinginhypertrophiccardiomyopathycomparedtohypertensiveheartdiseaseandathleteshearts
AT rotenlaurent differencesinatrialremodelinginhypertrophiccardiomyopathycomparedtohypertensiveheartdiseaseandathleteshearts